Regional Challenges in Regulating Medical Product AI: A Discussion of the Different Regulatory Approaches in the US, EU, and UK

Join us for a discussion of recent legal and regulatory developments in the United States, the European Union, and the United Kingdom relating to the use of artificial intelligence in the life sciences industry. The participants leverage their experiences with a wide range of digital health technology and other clients to explore the similarities and differences in each region's approach to AI regulation, the impact of these approaches on industry stakeholders, and expectations for further AI legislation and regulation. 

The program will explore: 

• The evolution of AI regulation in the life sciences industry •Recent legislative initiatives, such as the EU's AI Act, and regulatory developments for AI 
• The effects of AI laws and regulations on the pharmaceutical and medical device companies
• Trends and expectations for future AI regulation and opportunities for advocacy 

Panelists include M. Jason Brooke of Brooke & Associates, Alison Dennis of Taylor Wessing and Ben Zegarelli of Mintz.